Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Ovarian Cancer
100%
Secondary Cytoreductive Surgery
100%
Stage III-IV
100%
Carbohydrate Antigen 125 (CA125)
100%
Proteomics
100%
Ovarian Cancer Screening
66%
Cancer Risk Index
66%
Ovarian Cancer Patients
33%
Incomplete Cytoreduction
33%
Cytoreduction
33%
Outcome Prediction
16%
Early Diagnosis
16%
Pelvic Tumor
16%
Primary Surgery
16%
Residual Disease
16%
Receiver Operating Characteristic Curve
16%
Marker Panel
16%
Area under the Receiver Operating Characteristic (AUROC)
16%
Prognostic Information
16%
New Biomarkers
16%
Surface-enhanced Laser Desorption/ionization Time-of-flight Mass Spectrometry
16%
Medicine and Dentistry
Ovarian Cancer
100%
Proteomics
100%
CA-125
75%
Biological Marker
62%
Sensitivity and Specificity
25%
Prospective Study
12%
Early Diagnosis
12%
Pelvic Tumor
12%
Minimal Residual Disease
12%
Surface Enhanced Laser Desorption Ionization Time of Flight Mass Spectrometry
12%